(Q51559180)

7 April 2018

title

Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study. (English)

1 reference

7 April 2018

1 reference

1 reference

9

1 reference

7 April 2018

H. Clifford Lane

11

object named as

Lane HC

1 reference

7 April 2018

author name string

Falloon J

1

1 reference

7 April 2018

Sargent S

2

1 reference

7 April 2018

Piscitelli SC

3

1 reference

7 April 2018

Bechtel C

4

1 reference

7 April 2018

LaFon SW

5

1 reference

7 April 2018

Sadler B

6

1 reference

7 April 2018

Walker RE

7

1 reference

7 April 2018

Kovacs JA

8

1 reference

7 April 2018

Davey RT Jr

10

1 reference

7 April 2018

Masur H

12

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 September 1999

1 reference

7 April 2018

published in

Pharmacotherapy

1 reference

7 April 2018

volume

19

1 reference

7 April 2018

issue

9

1 reference

7 April 2018

page(s)

1050-1056

1 reference

7 April 2018

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.13.1050.31598

Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.13.1050.31598

A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.13.1050.31598

Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.13.1050.31598

Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.13.1050.31598

Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.13.1050.31598

High-performance liquid chromatographic assay for the measurement of atovaquone in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.13.1050.31598

Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.13.1050.31598

10.1592/PHCO.19.13.1050.31598

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

release_sxusrbpxhzetllrc6zuggp2rwu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sxusrbpxhzetllrc6zuggp2rwu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10610011

1 reference

7 April 2018